SLNO vs. CBZ

Last updated Apr 1, 2026

Compare and contrast key facts about Soleno Therapeutics, Inc. (SLNO) and CBIZ, Inc. (CBZ).

Performance

SLNO vs. CBZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Soleno Therapeutics, Inc. (SLNO) and CBIZ, Inc. (CBZ). The values are adjusted to include any dividend payments, if applicable.

SLNO vs. CBZ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SLNO Soleno Therapeutics, Inc.	-27.69%	3.00%	11.68%	1,932.83%	-67.80%	-78.76%	-34.35%	71.93%	-5.00%	-55.56%
CBZ CBIZ, Inc.	-46.78%	-38.35%	30.74%	33.60%	19.76%	47.01%	-1.30%	36.85%	27.51%	12.77%

Fundamentals

EPS SLNO : $0.39 CBZ : $1.63
PE Ratio SLNO : 85.34 CBZ : 16.42
PS Ratio SLNO : 9.36 CBZ : 0.64
Total Revenue (TTM) SLNO : $190.41M CBZ : $2.68B
Gross Profit (TTM) SLNO : $96.84M CBZ : $344.24M
EBITDA (TTM) SLNO : $9.41M CBZ : $445.55M

Returns By Period

In the year-to-date period, SLNO achieves a -27.69% return, which is significantly higher than CBZ's -46.78% return. Over the past 10 years, SLNO has underperformed CBZ with an annualized return of -9.78%, while CBZ has yielded a comparatively higher 10.22% annualized return.

SLNO

• 1D: 9.99%
• 1M: -14.31%
• YTD: -27.69%
• 6M: -50.47%
• 1Y: -53.14%
• 3Y*: 150.11%
• 5Y*: 11.25%
• 10Y*: -9.78%

CBZ

• 1D: -0.59%
• 1M: -6.25%
• YTD: -46.78%
• 6M: -49.30%
• 1Y: -64.61%
• 3Y*: -18.44%
• 5Y*: -4.09%
• 10Y*: 10.22%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SLNO vs. CBZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SLNO

SLNO Risk / Return Rank: 10
SLNO Sharpe Ratio Rank: 8
SLNO Sortino Ratio Rank: 10
SLNO Omega Ratio Rank: 10
SLNO Calmar Ratio Rank: 12
SLNO Martin Ratio Rank: 10

CBZ

CBZ Risk / Return Rank: 3
CBZ Sharpe Ratio Rank: 1
CBZ Sortino Ratio Rank: 2
CBZ Omega Ratio Rank: 2
CBZ Calmar Ratio Rank: 6
CBZ Martin Ratio Rank: 3

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SLNO vs. CBZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Soleno Therapeutics, Inc. (SLNO) and CBIZ, Inc. (CBZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SLNO	CBZ	Difference
Sharpe ratio Return per unit of total volatility	-0.83	-1.26	+0.43
Sortino ratio Return per unit of downside risk	-1.09	-2.15	+1.06
Omega ratio Gain probability vs. loss probability	0.86	0.71	+0.15
Calmar ratio Return relative to maximum drawdown	-0.81	-0.94	+0.13
Martin ratio Return relative to average drawdown	-1.51	-1.84	+0.33
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SLNO vs. CBZ - Sharpe Ratio Comparison

The current SLNO Sharpe Ratio is -0.83, which is higher than the CBZ Sharpe Ratio of -1.26. The chart below compares the historical Sharpe Ratios of SLNO and CBZ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SLNO	CBZ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.83	-1.26	+0.43
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.05	-0.12	+0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.05	0.34	-0.39
Sharpe Ratio (All Time) Calculated using the full available price history	-0.09	0.16	-0.25

Correlation

The correlation between SLNO and CBZ is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SLNO vs. CBZ - Dividend Comparison

Neither SLNO nor CBZ has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

SLNO vs. CBZ - Drawdown Comparison

The maximum SLNO drawdown since its inception was -99.86%, roughly equal to the maximum CBZ drawdown of -96.13%. Use the drawdown chart below to compare losses from any high point for SLNO and CBZ.

Drawdown Indicators

	SLNO	CBZ	Difference
Max Drawdown Largest peak-to-trough decline	-99.86%	-96.13%	-3.73%
Max Drawdown (1Y) Largest decline over 1 year	-66.04%	-68.43%	+2.39%
Max Drawdown (5Y) Largest decline over 5 years	-95.49%	-71.64%	-23.85%
Max Drawdown (10Y) Largest decline over 10 years	-99.13%	-71.64%	-27.49%
Current Drawdown Current decline from peak	-94.90%	-69.71%	-25.19%
Average Drawdown Average peak-to-trough decline	-90.57%	-50.96%	-39.61%
Ulcer Index Depth and duration of drawdowns from previous peaks	35.50%	34.96%	+0.54%

Volatility

SLNO vs. CBZ - Volatility Comparison

Soleno Therapeutics, Inc. (SLNO) has a higher volatility of 17.95% compared to CBIZ, Inc. (CBZ) at 14.91%. This indicates that SLNO's price experiences larger fluctuations and is considered to be riskier than CBZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SLNO	CBZ	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.95%	14.91%	+3.04%
Volatility (6M) Calculated over the trailing 6-month period	50.62%	39.25%	+11.37%
Volatility (1Y) Calculated over the trailing 1-year period	64.08%	51.33%	+12.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	243.38%	32.88%	+210.50%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	185.10%	30.20%	+154.90%

Financials